Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) EBT (2016 - 2025)

Historic EBT for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to $55.9 million.

  • Select Medical Holdings' EBT rose 2251.7% to $55.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $207.3 million, marking a year-over-year decrease of 767.61%. This contributed to the annual value of $174.8 million for FY2024, which is 2508.16% up from last year.
  • Select Medical Holdings' EBT amounted to $55.9 million in Q3 2025, which was up 2251.7% from $70.2 million recorded in Q2 2025.
  • Over the past 5 years, Select Medical Holdings' EBT peaked at $261.9 million during Q2 2021, and registered a low of -$179.0 million during Q4 2022.
  • In the last 5 years, Select Medical Holdings' EBT had a median value of $55.9 million in 2025 and averaged $63.3 million.
  • Its EBT has fluctuated over the past 5 years, first crashed by 41042.08% in 2022, then skyrocketed by 55882.52% in 2024.
  • Select Medical Holdings' EBT (Quarter) stood at $57.7 million in 2021, then plummeted by 410.42% to -$179.0 million in 2022, then skyrocketed by 119.48% to $34.9 million in 2023, then tumbled by 142.85% to -$14.9 million in 2024, then skyrocketed by 474.28% to $55.9 million in 2025.
  • Its EBT stands at $55.9 million for Q3 2025, versus $70.2 million for Q2 2025 and $96.2 million for Q1 2025.